Clinical trial reportJournal of Crohn's & colitisPublished
Safety and tolerability of anti-toll-like receptor 3, monoclonal antibody PRV-300 in patients with moderate-to-severe ulcerative colitis: a randomized phase 1B clinical trial (PULSE)
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Journal of Crohn's & colitis
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Colitis, Ulcerative; Antibodies, Monoclonal; Treatment Outcome; Severity of Illness Index; Double-Blind Method; Adult; Middle Aged; Female; Male; Toll-Like Receptor 3; Antibodies, Monoclonal, Humanized
- PubMed ID
- 42896861
- PubMed Central ID
- PMC13680009
- Open access
- Yes, open
- Added to directory
- Source checked